Posted by king36 > 2017-11-05 04:29 | Report Abuse

@ sitia - See posting
Posted by kevin5059 > Oct 31, 2017 11:18 AM | Report Abuse
I share the same view.

Posted by sitia > 2017-11-05 19:30 | Report Abuse

I think 38cents will not materialized. I hope David Ho can revise a better price position for us. We have been loyal to you. haha

Posted by sitia > 2017-11-05 19:30 | Report Abuse

I don't think Fong Siling will do open trade on Bursa with David Ho. They could do it closed door.

Posted by sitia > 2017-11-05 19:34 | Report Abuse

king36, I shared the same view too. Unfortunately, after delist and you still hove the shares, u are not able to trade at all. Your money is stucked in Hovid's account.

Most people will sell, to be honest with you. If the difference they made from Hovid as at now is few cents, they won't be bothered to wait so long.

There are plenty of stocks in Bursa that can fetch even better price and profits. Why bother with Hovid????

Posted by simon2020 > 2017-11-05 22:56 | Report Abuse

Actually there should be no hurry to sell...as there is still the Independent Advice Circular to be received no later than 9 Nov. before deciding and you don't have to take any action if decided not to accept the offer of RM0.38 per share.

20 Nov is only the first closing date, or any other closing date the Joint Offerors may decide as may be announced by CIMB at least 2 days before the closing date i.e. 18 Nov.

Posted by multi530 > 2017-11-06 15:16 | Report Abuse

it just a bet either outcome is a "big or a small". I hope the offer price can adjust to 20% more. I dun mind to buy another 10 lots.

Posted by sitia > 2017-11-06 17:37 | Report Abuse

multi530, 20% I'm very happy already.

Posted by wannabeinvestor > 2017-11-06 18:17 | Report Abuse

this is my worst investment..2yrs ago i bought .485 now take over .38 con man company..

Posted by wannabeinvestor > 2017-11-06 18:19 | Report Abuse

just received take over offer circular today..damn it

Posted by red_85 > 2017-11-07 00:31 | Report Abuse

See pjdev case..better don't bet..better just accept, or else he might let the price down nonstop and offer a lower price..don't bet with bad boss..he hold majority of the share, if take over failed, he can just let the price slowly drop and offer new price maybe next year at much lower price..he can control everything..this is bad boss,

Posted by Czarll > 2017-11-07 09:05 | Report Abuse

value investor is u drop more they buy more.....

Posted by kevin5059 > 2017-11-07 09:33 | Report Abuse

How much lower he can drop the price. Remember, the take over price must be more than the NTA, or else SC will not approve. Unless they make their business losses like no tomorrow and drop the NTA to 10sen. Then take over from you at 15sen.

Posted by simon2020 > 2017-11-07 10:06 | Report Abuse

Looks like the takeover response is not too good... otherwise we won't have promoters here for HSS...anyway PJdev is not a good example as is in a different industry segment...one is property development which is in a slowdown, while Hovid is in medical & health industry which is defensive...even in bad times it is still profitable so will be even better in good times

Posted by Asria > 2017-11-07 10:17 | Report Abuse

just keep it wait for fair offer

Posted by multi530 > 2017-11-07 11:28 | Report Abuse

Czarll,
value investor is Hovid drop more I buy more....ha ha ha

Posted by multi530 > 2017-11-07 11:36 | Report Abuse

as at Sept 26, 2017...HSS got 111m shares pledged with HLB. Wondering how much he can affort if price drop.

Posted by kevin5059 > 2017-11-07 14:51 | Report Abuse

Let me share the reason why I buy HOVID, even at this so called peak season of stock market. Even that during the crisis, maybe next year or maybe iin 2019, I believe that HOVID going to do well.

Just amazing that you are head of procurement in a clinic or a hospital. During the economy crisis, your department will definitely get headcount or expenses cut. So when you get expenses cut, what will you do? You will look for "cheaper" way to get your medication, and HOVID is one of them. For similar medication product, due to the geographical location as compared to US, Europe or Autralia (which most of the drug manufacturer located), HOVID can provide a similar quality of medication with lower cost. Will you switch to buy from HOVID or still buying from overseas? Not to forget the currency exchange rate that cause of weak RM? Keep your answer and decide you want to sell to David Ho at Rm0.38 now or not.

HOVID should become a very hot stock next year. So don kill the chicken that lay a golden eggs. Be patient.

Posted by Ming Tzy > 2017-11-07 16:32 | Report Abuse

offer price at 0.38 is totally not fair.I bet cold eye will choose to hold his hovid share.

Posted by kevin5059 > 2017-11-07 16:39 | Report Abuse

My maybank remisier just called me about my decision, and I said NO, I'm going to keep my share.

Posted by Czarll > 2017-11-07 16:48 | Report Abuse

you all look like standby to singing a song to David ho.....
m.Jackson -
.....You are not alone
I am here with you.....

Posted by Tze Xin Tze Yiu > 2017-11-07 21:06 | Report Abuse

When everyone keep , is time to sell, is everyone sell is time to keep. Seem everyone is keeping so that shall sell

Posted by Ming Tzy > 2017-11-08 09:02 | Report Abuse

ya..u can use ur back side to eat because everyone use mouth..reverse theory!!!

Posted by smartly > 2017-11-08 16:21 | Report Abuse

holding for too long already....

Posted by smartly > 2017-11-08 16:25 | Report Abuse

take the money and go else loss opportunity cost....

Posted by multi530 > 2017-11-08 17:32 | Report Abuse

https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=109404888

Posted by multi530 > 2017-11-08 17:33 | Report Abuse

some background of HSS's partner

Posted by wongchin > 2017-11-08 18:26 | Report Abuse

Yes today remisier also call me. My answer decline the low offer

Posted by Supertonic000 > 2017-11-08 21:14 | Report Abuse

I'm wondering what will be the price movement if the offer is not successful ...

Posted by simon2020 > 2017-11-09 02:09 | Report Abuse

Don't worry they will try to make it successful since Tael Partners has identified Hovid's as a growth oriented investment ripe for acquisition camouflaged as "Privatisation Exercise". Once they successfully acquire Hovid at a bargain price, they will sell their shares profitably to the highest bidder or relist again as a new entity in one to 2 years time. If they can't achieve 90%, they will sweetend the offer by raising the offer price. If they achieved 90% there will be a mandatory acquisition.

If their offer is not successful...Mr. Market already knows the true value of Hovid which is RM0.38 sens and above, otherwise a market savvy investor like Cold Eyed would not have bought 10 million shares in Hovid...

Quote"
HSS partner Tael Partners Ltd is a principal investment firm specializing in growth oriented investments.

Their Target is:
Merger/Acquisition
October 9, 2017 Hovid Berhad "

Quote "Hovid appears to be an attractive merger acquisition target for foreign pharmaceutical giants looking for capacity expansion in this part of the world and Tael Partners may sell their share of Hovid should the acquisition be successful to the highest bidders at a handsome profit"

http://www.theedgemarkets.com/article/hovid-inflection-point

Some Case Studies on Merger & Acquisition for bedtime reading
http://governanceforstakeholders.com/wp-content/uploads/2013/03/Corpor...

Posted by kevin5059 > 2017-11-09 09:43 | Report Abuse

If this round of acquisition not successful. Just prepare to buy more at lower price. Market will has packet sell and grab that opportunity before it slip off.

Posted by choyminwai > 2017-11-09 09:45 | Report Abuse

If don't sell but acquisition successful, the share on hand will be no meaning ...

Posted by simon2020 > 2017-11-09 09:57 | Report Abuse

Don't worry if the acquisition is succesful i.e. HSS & partner achieved 90% shares...they will activate mandatory acquisition and buy the shares from you without you doing anything...

the main thing is to force them to offer us a better price than 38 sens before they can achieve 90% by 20/11 which I think is not possible...so they will up the offer price and extend the deadline for acquisition just like MBFH case...

Posted by Ming Tzy > 2017-11-09 10:59 | Report Abuse

100% not successful..u see the volume u can predict the share movement.

Posted by multi530 > 2017-11-09 17:46 | Report Abuse

pls read IA comments... :(

Posted by sitia > 2017-11-09 19:01 | Report Abuse

can they still delist if majority don't want to sell it???

Posted by sitia > 2017-11-09 19:09 | Report Abuse

then hovid will still be in market. definitely lower price nobody wanna sell.

Posted by Syndicates > 2017-11-09 20:05 | Report Abuse

less than 90% of acceptance then wont delist. but acceptance rate will getting higher after the IA comments.

Posted by HouSuSah > 2017-11-09 20:39 | Report Abuse

Aiyo why don't want accept? Why not we all collect now to make arbitrage profit?

You guys must be holding above 38 sen ,that's why don't want to sell. Don't know what is CUT LOST ah?

You guys must be suffering a lot when its license is revoked , want to suffer a deep dive again?

You guys are confident with this company. Why you guys don't want to average down when their license revoked? If you guys do so your cost is lower than offer price now.

Posted by simon2020 > 2017-11-09 22:07 | Report Abuse

You guys must be promoters from HSS's side...nobody will not accept if the price is right!...the main idea is to force HSS and Tael Partners Ltd the principal investment firm specializing in growth oriented investments (whose main target is : Merger/Acquisition of Hovid Berhad thorugh this privatisation exercise) to offer us a better price than 38 sens before they can achieve 90% by 20th November which is only the first deadline...so they will up the offer price and extend the deadline for acquisition just like MBFH case...

https://klse.i3investor.com/servlets/stk/ta/1236.jsp

Posted by simon2020 > 2017-11-09 22:23 | Report Abuse

Points for Minority Shareholders consideration:

Now, for minority shareholders who were unfazed by the suspension of production in January and have held onto their shares, should they take up the takeover offer to exit at this point of time? But it may be worth noting that the company posted earnings per share of 2.24 sen for FY16.
https://edgemarkets.s3-ap-southeast-1.amazonaws.com/pictures/Hovid_Chart_fd_161017_theedgemarkets.jpg

There is a wild card that minority shareholders should not neglect — the new capacity which has been delayed. The extension of capacity is expected to come on stream by year end, according to a fund manager.

According to CIMB, the Chemor plant extension could raise Hovid’s existing tablet and capsule capacity by 70% (from the original capacity). But this will happen gradually.

The new capacity will translate into stronger earnings growth in future for Hovid when things are falling in place. This may be why Fajar Astoria is keen on pouring in money to take Hovid private — a deal that will cost them about RM243.1 million.

Hovid’s production facilities include the 20-acre (8.09ha) Chemor plant with softgel packing, effervescent dosage and oral solid dosage facilities, while its three-acre Ipoh plant, where its headquarters are in, produces softgel encapsulation, oral liquid, penicillin products and its heritage Ho Yan Hor herbal tea.

Aside from the manufacturing plants, Hovid has a research and development centre in Penang which is dedicated to bioequivalence studies.

With a market capitalisation of RM295 million, which is less than US$85 million, Hovid does appear to be an attractive merger and acquisition (M&A) target for foreign pharmaceutical giants that are looking for capacity expansion in this part of the world. In fact, CIMB said that it would turn more positive on Hovid upon a stronger-than-expected recovery in sales volume and earlier delivery of the extension of its Chemor plant.

http://www.theedgemarkets.com/article/hovid-inflection-point

Posted by Tze Xin Tze Yiu > 2017-11-10 09:23 | Report Abuse

When everyone is buying , we shall sell... when everyone is sell we shall buy. Rules of share

Posted by Asria > 2017-11-10 09:27 | Report Abuse

just keep the share dont sale wait a better offer

Posted by Lim Ys > 2017-11-10 09:37 | Report Abuse

Wait for higher offer price. Not going to sell at RM0.38.
Pls take note also on the forthcoming patent cliffs, which will see the patent expires of many blockbuster drugs. Good news for generic drug manufacture.
https://www.uspharmacist.com/article/drug-patent-expirations-and-the-patent-cliff

Posted by Czarll > 2017-11-10 09:41 | Report Abuse

找不到接受献够的理由，只找到不断买入的理由。从基本面的角度，产能提升，r

Posted by Czarll > 2017-11-10 10:33 | Report Abuse

找不到接受献够的理由，只找到不断买入的理由。从基本面的角度，产能提升，r

Posted by pundekman > 2017-11-10 14:42 | Report Abuse

aiyo never accept the first offer la. simple as that

Posted by Learntoearn > 2017-11-10 19:21 | Report Abuse

Just decline their offer!

Posted by Ledangking > 2017-11-11 14:38 | Report Abuse

Hovid`s business can generate cash flow that beyond 0.50. 0.38 is very cheap offer. We should object the offer.

Posted by kcwong98 > 2017-11-11 17:25 | Report Abuse

https://www.thestar.com.my/business/business-news/2017/11/10/offer-for-hovid-deemed-fair-and-reasonable/

Posted by kcwong98 > 2017-11-11 22:42 | Report Abuse

Mine is hovid wb only have 1 more year lifespan. If they privatised, i have to top up Rm 0.20 1 year later to exercise. Too risky for me. I take profit to invest somewhere. I bilis can't fight with shark .